4481 related articles for article (PubMed ID: 3127479)
1. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
McEwan M; Parsons PG; Moss DJ
J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.
McEwan M; Parsons PG; Moss DJ; Burrows S; Stenzel D; Bishop CJ; Strutton GM
Pigment Cell Res; 1989; 2(1):1-7. PubMed ID: 2470076
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes.
Tomita Y; Hearing VJ
Diagn Immunol; 1986; 4(3):149-54. PubMed ID: 3089671
[TBL] [Abstract][Full Text] [Related]
4. Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes.
Tomita Y; Montague PM; Hearing VJ
J Invest Dermatol; 1985 Nov; 85(5):426-30. PubMed ID: 2414367
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
Fuller BB; Iman DS; Lunsford JB
J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
Imokawa G; Mishima Y
Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
[TBL] [Abstract][Full Text] [Related]
7. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
Tomita Y; Hariu A; Kato C; Seiji M
Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
[TBL] [Abstract][Full Text] [Related]
8. Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.
Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H
Pigment Cell Res; 1996 Dec; 9(6):298-303. PubMed ID: 9125753
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen YT; Stockert E; Tsang S; Coplan KA; Old LJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8125-9. PubMed ID: 7667256
[TBL] [Abstract][Full Text] [Related]
10. Mammalian monophenol monooxygenase (tyrosinase): purification, properties, and reactions catalyzed.
Hearing VJ
Methods Enzymol; 1987; 142():154-65. PubMed ID: 3110555
[No Abstract] [Full Text] [Related]
11. MAT-1, a monoclonal antibody that specifically recognizes human tyrosinase.
Takimoto H; Suzuki S; Masui S; Shibata K; Tomita Y; Shibahara S; Nakano H
J Invest Dermatol; 1995 Dec; 105(6):764-8. PubMed ID: 7490469
[TBL] [Abstract][Full Text] [Related]
12. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
Bouchard B; Fuller BB; Vijayasaradhi S; Houghton AN
J Exp Med; 1989 Jun; 169(6):2029-42. PubMed ID: 2499655
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of three hamster melanoma variants--I. Tyrosinase activity and melanin content.
Słomiński A; Scisłowski PW; Bomirski A
Int J Biochem; 1984; 16(3):323-6. PubMed ID: 6421636
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
Słomiński A; Scisłowski PW; Bomirski A
Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
[TBL] [Abstract][Full Text] [Related]
15. Microheterogeneity of melanosome-bound tyrosinase from the Harding-Passey murine melanoma.
Ferrini U; Mileo AM; Hearing VJ
Int J Biochem; 1987; 19(3):227-34. PubMed ID: 3109972
[TBL] [Abstract][Full Text] [Related]
16. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
[TBL] [Abstract][Full Text] [Related]
17. Cellular localization of tyrosinase in human malignant melanoma cell lines.
Foa C; Aubert C
J Invest Dermatol; 1977 Jun; 68(6):369-78. PubMed ID: 405430
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition by antityrosinase antibodies of tyrosinase-mediated melanogenesis.
Vachtenheim J; Duchon J; Matous B; Vulterin K
J Invest Dermatol; 1986 May; 86(5):573-6. PubMed ID: 3091707
[TBL] [Abstract][Full Text] [Related]
19. Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion.
Yurkow EJ; Laskin JD
Arch Biochem Biophys; 1989 Nov; 275(1):122-9. PubMed ID: 2510599
[TBL] [Abstract][Full Text] [Related]
20. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
